Clouds Over the Capitol

TRIPS Waiver, MCIT, HR3.  If you are not familiar with these policy developments, you probably should be.

The United States medtech and biotech industries make a tremendous impact on people’s lives.   When policy makers and Federal Agencies work together, the impact is made even greater.  However, some policy decisions can have the opposite effect.

Continue reading

Opinion: Now is absolutely not the time to be complacent

In the pandemic’s 17th month, we live in a world of vivid contrast between early-vaccinating countries that appear to be approaching an end to their epidemic and those falling rapidly into the abyss. Brazil and India are suffering escalating COVID caseloads exhausting health care resources. The long haul with the virus in the US and the current situation in Brazil and India have clearly underscored the importance of a strong, coordinated, and sustained public health response.

Continue reading

C-Path Appoints Quantitative Sciences Expert as New Sr. Vice President

Dr. Jeff Barrett will lead C-Path’s RDCA-DAP initiative focusing on rare disease data sharing and accelerating therapy development.

TUCSON, Ariz. May 6, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jeff Barrett, Ph.D., F.C.P., as Senior Vice President and lead for its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) initiative.Continue reading

AdvaMed Announces New Hybrid Structure for The MedTech Conference 2021

WASHINGTON, D.C. – The MedTech Conference, powered by AdvaMed, will host its trademark award-winning programming and networking opportunities in a new hybrid structure, combining the benefits of both in-person and virtual events, on September 27th – 30th. Attendees can participate in The MedTech Conference in a fully virtual environment, and they can also take advantage of limited-capacity in-person gatherings in Washington, D.C. and in Minneapolis, Minnesota.Continue reading

NuvOx Completes Construction of Expanded Manufacturing Facility.

TUCSON, Ariz.–(BUSINESS WIRE)–NuvOx Pharma has completed construction and initiated operation of its GMP production facility for manufacturing its injectable pharmaceutical products at its Tucson, Arizona facility. Construction of the GMP facility was financed by ImaRx Investments, LLC. The facility comprises an 1,800 square foot hard shell exterior space addition to the existing building located at 1635 East 18th Street. A 900 square foot ISO 5 cleanroom is housed within the exterior space.Continue reading

Mayo Clinic preclinical discovery triggers wound healing, skin regeneration

ROCHESTER, Minn. — Difficult-to-treat, chronic wounds in preclinical models healed with normal scar-free skin after treatment with an acellular product discovered at Mayo Clinic. Derived from platelets, the purified exosomal product, known as PEP, was used to deliver healing messages into cells of preclinical animal models of ischemic wounds. The Mayo Clinic research team documented restoration of skin integrity, hair follicles, sweat glands, skin oils and normal hydration.

Continue reading